Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older
Clinical trial NCT01751165 · COMPLETED
Trial details
- NCT number
- NCT01751165
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-12
- Primary completion
- 2014-05-22
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.